Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Suspicious

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 09, 2022 10:37pm

290 Views

Post# 34669257

RE:RE:RE:Suspicious

They have done foolish things before. You think a company will give them rights to or a cell line for nothing? Vertex bought Semma cells for 1 billion. The way the share price is being held is very suspect. Unless the company is unknown or they aren't looking to acquire cells, it smells fishy to me. Just because the target is 3 doesn't mean it'll happen.